1367594-59-9

Basic information

• Product Name: (4R,4aS,6R,7R,7aR,12bS)-6-((benzyloxy)methyl)-3-(cyclopropylmethyl)-9-methoxy-7-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinoline
• Synonyms: (4R,4aS,6R,7R,7aR,12bS)-6-((benzyloxy)methyl)-3-(cyclopropylmethyl)-9-methoxy-7-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinoline
• CAS NO: 1367594-59-9
• Molecular Weight: 633.825
• Mol File: 1367594-59-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (4R,4aS,6R,7R,7aR,12bS)-6-((benzyloxy)methyl)-3-(cyclopropylmethyl)-9-methoxy-7-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: (4R,4aS,6R,7R,7aR,12bS)-6-((benzyloxy)methyl)-3-(cyclopropylmethyl)-9-methoxy-7-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinoline(1367594-59-9)
• EPA Substance Registry System: (4R,4aS,6R,7R,7aR,12bS)-6-((benzyloxy)methyl)-3-(cyclopropylmethyl)-9-methoxy-7-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinoline(1367594-59-9)

Safety Data

• Hazardous Substances Data: 1367594-59-9(Hazardous Substances Data)

Upstream product

• 1367597-47-4 C₂₄H₃₁NO₄ 
• 1367597-45-2 C₂₆H₃₃NO₅ 
• 1367597-42-9 C₂₆H₃₁NO₅ 
• 24997-74-8 17-cyclopropylmethyl-4,5α-epoxy-3,6-dihydroxy-6α,14α-etheno-morphinane-7α-carboxylic acid ethyl ester 
• 24997-66-8 ethyl 17-(cyclopropylmethyl)-4,5α-epoxy-3,6β-dimethoxy-6,14-endoethenomorphinan-7α-carboxylate 
• 2579-67-1 northebaine 
• 5083-80-7 N-(cyclopropylmethyl)northebaine 
• 1367595-39-8 (4R,4aS,6R,7R,7aR,12bS)-6-((benzyloxy)methyl)-3-(cyclopropylmethyl)-9-methoxy-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol 
• 74654-05-0 8-methoxy-1-(methylsulfonyl)oxy-3,6-dioxaoctane 

Relevant articles and documents

BUPRENORPHINE ANALOGS

The present invention is directed to Buprenorphine Analog compounds of the Formula (I), Formula (IA) or Formula (IB) shown below, wherein R1, R2, R8, R3a, R3b, G, X, Z and Y are as defined herein. Compounds of the Invention are useful for treating pain, constipation, and other conditions modulated by activity of opioid and ORL-1 receptors.